Biotechnology News

October 30, 2014

BOSTON--(BUSINESS WIRE)--The Joslin Institute for Technology Translation (JITT) announces that three Johnson & Johnson Diabetes Solutions Companies have joined JITT as Founding Members and as members of JITT’s Advisory Board.

October 30, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter presented the results of a Phase 2/3 study of its investigational 20 percent concentration subcutaneous immunoglobulin treatment for PI at ESID in Prague.

October 30, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Phase 2 Objective Response Rate&Survival Data for Opdivo(nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung Cancer to be Presented at 2014 Chicago Multidisciplinary Symposium

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, announced today that it will hold a conference call and live audio...

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics Announces Availability of Abstract with Preliminary Data from Phase 2 Study of BIND-014 in Non-small Cell Lung Cancer. Updated Data to be Presented at 26th EORTC-NCI-AACR Symposium.

October 30, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Brain insulin resistance is an abnormality in Alzheimer’s disease that contributes to neural cell damage and can be detected by a new blood test, according to a study published in The FASEB Journal.

October 30, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--RetroSense Therapeutics Granted Orphan Drug Designation for Lead Product RST-001 for Retinitis Pigmentosa. Unique approach combines gene therapy and optogenetics with the intention to treat blindness.

October 30, 2014

NEW YORK--(BUSINESS WIRE)--Recap of stories on Business Wire related to Ebola outbreak.

October 30, 2014

SOUTH PLAINFIELD & PRINCETON, N.J. & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces a collaboration with Admera...

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a...

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following four upcoming conferences in November: Nomura Biotechnology Conference, Boston, November 6th, panel at 12:15 p.m. ET (no...

October 30, 2014

RADNOR, Pa.& GÖTEBORG, Sweden--(BUSINESS WIRE)--Cortendo announced an agreement led by HealthCap for a private placement resulting in gross proceeds of approximately $11 million as well as plans to evaluate a U.S. financing and listing...

October 30, 2014

NEW YORK--(BUSINESS WIRE)--Manhattan Scientifcs has engaged Dian Griesel Int'l to manage its media relations. DGI will work toward the objective of increasing awareness of the company and its subsidiary, Senior Scientific.

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (NASDAQ:XLRN) will host a conference call and live audio webcast to report its third quarter 2014 financial results and provide a corporate update on Friday, November 7, 2014.

October 30, 2014

SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences announces FDA approval to start IDE clinical trial for its novel ONCOZENE™ embolic microspheres, loaded with doxorubicin, a chemotherapy drug used in the treatment of HCC.

October 30, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea's Lymphoseek results for melanoma, breast or head/neck cancer studies presented at the European Association of Nuclear Medicine & this week's European Society of Surgical Oncology Congress.

October 30, 2014

LISLE, Ill.--(BUSINESS WIRE)--Molex MediSpec™ MID/LDS Blends Advanced Technologies In Compact 3D Package

October 30, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Third Quarter 2014 Financial Results Teleconference and Webcast

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Affinivax Inc., a biotechnology company dedicated to developing novel vaccines, today announced that it has appointed Frances K. Heller to the company’s Board of Directors.

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Affinivax Inc., a biotechnology company dedicated to developing novel vaccines, today announced its launch with a $4 million investment from the Bill & Melinda Gates Foundation.

October 30, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today reported 2014 third-quarter financial results, including revenue from Jakafi® (ruxolitinib). The Company highlighted the strength in Jakafi sales in the U.S. as well as...

October 30, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2014 financial results before the market opens on Thursday, November 6, 2014 and host a conference call at 8:30 a.m. ET (Eastern...

October 30, 2014

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2014 fourth quarter ended September 30, 2014, adjusted diluted earnings per share from continuing operations increased 35.8...

October 30, 2014

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ:TBIO) today reported financial results for the third quarter ended September 30, 2014, and provided a business update. Third Quarter Financial Results Net sales for the third quarter of...

October 30, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced that the U.S. Food and Drug Administration has approved once-daily XIGDUO™ XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with...

October 30, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Eighth paragraph should read: FAMPYRA® (prolonged-release fampridine tablets) - For the quarter ended September 30, 2014, the Company reported FAMPYRA royalties from sales outside of the U.S. of $2.5 million...

October 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the third quarter ended September 30, 2014.

October 30, 2014

BANGKOK--(BUSINESS WIRE)--Phyathai Nawamin International Hospital opened the Spine and Brain Center to support International patients. Our center prefers non-surgical treatment.

October 30, 2014

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIR-B) announces that the company has entered into an agreement with Swedish county councils regarding the treatment of hepatitis C with Olysio® (simeprevir). The Dental and...

October 30, 2014

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage (STO:BIOTA): Third quarter July – September 2014 · Group net sales in the third quarter 2014 amounted to 118.5 MSEK (103.4), an increase by 14.6 percent compared to the corresponding...

October 29, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported financial results for the quarter ended September...

October 29, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the acquisition of Ceiba Solutions, Inc., a sciences and laboratory IT software and...

October 29, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories has issued its third-quarter 2014 financial results and also announced the acquisition of ChanTest Corporation

October 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the third quarter ending September 30, 2014 on Wednesday, November 5,...

October 29, 2014

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ:IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its third quarter ended...

October 29, 2014

GALILEE, Israel--(BUSINESS WIRE)--MIGAL Galilee Research Institute announces the establishment of the first Agro-Biomedical center. The center is at one of the world's most famous developed agro regions north to the Sea of Galilee

October 29, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--EvaluatePharma Orphan Drug Report 2014 finds that orphan drug market to reach $176 Billion by 2020.

October 29, 2014

NEWTON, Mass.--(BUSINESS WIRE)--KOLs recognize clinical and economic benefits of noninvasive fluid management to hospitals and US health care system

October 29, 2014

SOUTH PLAINFIELD, N.J.--(BUSINESS WIRE)--Vention Medical Expands Catheter Center of Excellence in Minneapolis. New facility integrates design, development and manufacturing under one roof

October 29, 2014

BREMEN, Germany & BURLINGTON, Mass.--(BUSINESS WIRE)--Clinical CT Lung Screening: Learn How to Do It Well With MeVis Medical Solutions and Lahey Hospital & Medical Center

October 29, 2014

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation reported preliminary revenue results for the first quarter of 2015.

October 29, 2014

HERNDON, Va. & WESTBOROUGH, Mass.--(BUSINESS WIRE)--Exostar launches ProviderPass, a turn-key, SaaS identity authentication solution. eClinicalWorks selects ProviderPass to expand its EHR product so providers can e-prescribe controlled...

October 29, 2014

MADISON, Wisconsin & PLANEGG, Germany--(BUSINESS WIRE)--Biomax Informatics AG accelerates US expansion, announces the opening of its US headquarters near Madison, Wisconsin.

Jonathan M. Sheridan named new CEO of Biomax Informatics,...

October 29, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences announced today that Meriter-UnityPoint Health will now offer Cologuard, a noninvasive stool DNA screening test for colorectal cancer, in effort to get more patients screened.

October 29, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today announced that it will report financial results for the third quarter of 2014 on Wednesday,...

October 29, 2014

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. Announces Pricing of Private Offering of $175 Million of 7.50% Convertible Senior Notes

October 29, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that the U.S. Food and Drug Administration’s (FDA) Office of Orphan Products...

October 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND's President and CEO, Scott Minick, is scheduled to present at the Credit Suisse and Stifel Nicolaus Weisel healthcare conferences during November 2014.

October 29, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced the publication of a clinical study in the Journal of Clinical Psychiatry showing comparable sexual function in adult patients diagnosed with major depressive disorder (MDD)...